Other redox-active enzymes

Other redox-active enzymes is a broad classification used in pharmacological databases, such as ChEMBL, to group various oxidoreductases that do not fit into more specific, well-defined categories like Cytochrome P450s or specific dehydrogenases. These enzymes facilitate the transfer of electrons between molecules, a process fundamental to energy production, metabolic detoxification, and the maintenance of cellular redox balance (NCBI, 2023). Because this is a heterogeneous group, it includes diverse proteins such as thioredoxin reductase and xanthine oxidase, which are involved in various physiological processes from the synthesis of signaling molecules to the neutralization of reactive oxygen species (UniProt, 2024). In a therapeutic context, specific members of this group are targeted to treat conditions like cancer, where redox signaling is often dysregulated, or inflammatory disorders like gout (PubMed, 2022). Drugs interacting with these enzymes, such as allopurinol or auranofin, typically function by inhibiting catalytic activity to modulate metabolic flux or induce apoptosis in target cells (StatPearls, 2023). However, as a collective term, it does not represent a single pharmacological target but rather a functional class of enzymes, making it an imprecise descriptor for drug discovery purposes.

Other names

Redox enzymesMiscellaneous oxidoreductasesNon-classified redox enzymes

Inhibition or modulation of specific redox-active catalytic sites to alter electron transfer and metabolic flux.